As of January 22, 2025, Nuvectis Pharma (NVCT) has a market cap of $0.12 billion USD. According to our data, Nuvectis Pharma is ranked No.7567 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.12 B |
12.75%
|
Dec 31, 2024 | $0.10 B |
-35.13%
|
Dec 29, 2023 | $0.16 B |
11.20%
|
Dec 30, 2022 | $0.14 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Market Cap | = | NVCT Stock Price | * | NVCT Shares Outstanding |
= | $6.10 | * | 19.32 M | |
= | $0.12 B |